Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
申请人:DEVELOPMENT FINANCE CORPORATION
OF NEW ZEALAND
公开号:EP0025705A1
公开(公告)日:1981-03-25
Compounds represented by the general formula
in which R1 represents-CH3, -CH2CH3 or -(CH2)2 CH3;
R2 represents -CONHR4, -F, -Cl, -Br, -I,
-CF3, -N02, -NH2, -CH3, -OCH3 or-NHCOCH3, and
R3 represents -CONHR4, -H, -CH3 or -OCH3, with the proviso that at least one of R2 and R3 represents -CONHR4;
and R4 represents H, or -CH3, -CH2CH3, -(CH2)2CH3, -(CH2)3CH3 or - CH2CH(CH3)2, each optionally substituted with hydroxyl, amine and/or amide functions;
and acid addition salts thereof have antitumour properties.
由通式表示的化合物
其中 R1 代表-
CH3、- 或-(
CH2)2 ;
R2 代表-CONHR4、-F、-Cl、-Br、-I、
-
CF3、-N02、-NH2、- 、-O 或-NHCO ,以及
R3 代表-CONHR4、-H、- 或-O ,但 R2 和 R3 中至少有一个代表-CONHR4;
和 R4 代表 H、或- 、- 、-( )2 、-( )3 或- CH( )2,各自任选被羟基、胺和/或酰胺官能团取代;
及其酸加成盐具有抗肿瘤特性。